Frontlight ResearchEarly access
Endometrial cancer trials in United States
199 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- Where
- Boston, Fairfax, Houston, Irving, Nashville, Orlando
- Age
- 18 years and over
- People
- 180
- Run by
- ArriVent BioPharma, Inc.
See details and how to joinNCT07755436 - Phase 1Taking peopleFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Where
- Houston, La Jolla, Los Angeles, Minneapolis, Philadelphia
- Age
- 18 years and over
- People
- 119
- Run by
- Fate Therapeutics
See details and how to joinNCT07216105 - No phaseTaking peopleConcurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04839614 - No phaseTaking peopleFlyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
- Where
- Rochester
- Age
- 21 years and over
- People
- 44
- Run by
- Mayo Clinic
See details and how to joinNCT07662824 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Boston, Canton, Cerritos, Chicago, Coral Springs, Covington, Dearborn, Fairfax, Honolulu, Houston, Lakeland, Lake Success, Laredo, Las Vegas, Los Angeles, Margate, Miami, Nashville, Newnan, New York, Oklahoma City, Philadelphia, Pittsburgh, Plantation, San Diego, Seattle, Shirley, Silver Spring, St Louis, Tamarac, Washington D.C., Wilson
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 1Taking peopleA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Where
- Austin, Boston, Denver, Fairfax, New York, San Antonio, San Diego, Sarasota, Washington D.C.
- Age
- 18 years and over
- People
- 200
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07227168 - Phase 2Not yet taking people in United StatesA Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
- Where
- Chicago, Houston
- Age
- 18 years and over
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07349641 - Phase 1/2Taking peopleTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Los Angeles, Memphis, Minneapolis, New York, Orange, Palo Alto, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 12 months to 30 years
- People
- 147
- Run by
- Children's Oncology Group
See details and how to joinNCT04851119 - Phase 2Taking peopleA Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Where
- Anchorage, Atlanta, Aurora, Bethesda, Boston, Canton, Centerville, Chapel Hill, Charlottesville, Chicago, Cincinnati, Cleveland, Dallas, Detroit, Duarte, Eugene, Fort Myers, Fort Worth, Gainesville, Hackensack, Hilliard, Houston, Indianapolis, Iowa City, Kansas City, La Jolla, Little Rock, Los Angeles, Miami Beach, Milwaukee, Mobile, New Brunswick, New Haven, New Orleans, Newport Beach, New York, Oklahoma City, Orange, Palo Alto, Philadelphia, Phoenix, Pinehurst, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, Santa Monica, Seattle, Shreveport, Silver Spring, Sioux Falls, Spokane, Tucson, Urbana, Vancouver, Worcester
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Acrivon Therapeutics
See details and how to joinNCT05548296 · EU 2025-524542-10-00 - Phase 1Taking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Houston, Indianapolis, Los Angeles
- Age
- 18 years and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - Phase 1/2Taking peoplePersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Where
- Jacksonville
- Age
- 16 years and over
- People
- 138
- Run by
- Mayo Clinic
See details and how to joinNCT05269381 - No phaseTaking peopleHypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 60
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06538337 - No phaseTaking peopleDosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Where
- Milwaukee
- Age
- 65 years and over
- People
- 50
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07227077 - Phase 1/2Taking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Ann Arbor, Atlanta, Baltimore, Boston, Buffalo, Charlottesville, Chicago, Cincinnati, Grand Rapids, Hackensack, Maywood, New York, Philadelphia, Rochester, San Antonio, Seattle, Tampa, The Bronx
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - No phaseTaking peopleComparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 121
- Run by
- Mayo Clinic
See details and how to joinNCT04567771 - Phase 1Taking peopleA Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Where
- Boston, Charleston, Dallas, Denver, Fairfax, Hackensack, Houston, Maumee, Minneapolis, Nashville, New Haven, Oklahoma City, Philadelphia, San Antonio, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 150
- Run by
- Normunity AccelCo, Inc.
See details and how to joinNCT07182149 - Phase 1Taking peopleA Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- Where
- Charlotte, Columbus, Dallas, Detroit, Little Rock, Long Island City, Los Angeles, New York, Peoria, Philadelphia, Salt Lake City, Sarasota
- Age
- 18 years and over
- People
- 265
- Run by
- Whitehawk Therapeutics, Inc.
See details and how to joinNCT07470853 - Phase 1/2Taking peopleSacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 54
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06040970 - No phaseTaking peopleDevelopment of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 270
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07382583 - Phase 1/2Taking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Bethesda, Boston, Celebration, Columbus, Detroit, Houston, Kansas City, Madison, Miami, Nashville, Sacramento, San Antonio, Seattle
- Age
- 18 years and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - No phaseTaking peopleObservational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Where
- Allentown, Basking Ridge, Commack, Harrison, Hartford, Houston, Miami, Middletown, Montvale, New York, Orlando, Rochester, Rockville Centre
- Age
- 18 years and over
- People
- 1,715 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04291612 - Phase 4Not yet taking people in United StatesLow Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
- Where
- Jacksonville
- People
- 20
- Run by
- Mayo Clinic
See details and how to joinNCT07281547 - Phase 1Taking peopleStudy Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Where
- Austin, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Houston, Little Rock, Los Angeles, Peoria, San Antonio, Seattle
- Age
- 18 years and over
- People
- 226
- Run by
- Whitehawk Therapeutics, Inc.
See details and how to joinNCT07444814 - Phase 1/2Not yet taking people in United StatesStudy of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy
- Where
- East Brunswick, Lake Success, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 100
- Run by
- Gilead Sciences
See details and how to joinNCT07743541 - Phase 1Taking peoplePhase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
- Where
- Miami
- Age
- 18 years and over
- People
- 18
- Run by
- Aaron Wolfson
See details and how to joinNCT05603910